Vanguard Portfolio Management’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.3M Buy
510,032
+10,157
+2% +$258K ﹤0.01% 2109
2026
Q1
$12.5M Buy
+499,875
New +$11.8M ﹤0.01% 2047

Other funds holding ZYME

Vanguard Portfolio Management's ZYME Position: Q2 2026 in Review

Vanguard Portfolio Management increased its Zymeworks (ZYME) stake by 2% in Q2 2026, buying an estimated $258K and bringing the position to 510,032 shares worth $13.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2109.

Vanguard Portfolio Management first reported a position in ZYME in Q1 2026 and has held it in 2 quarters since. 201 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Vanguard Portfolio Management held 510,032 shares of Zymeworks worth $13.3M as of Q2 2026.
  • Vanguard Portfolio Management bought 10,157 Zymeworks shares in Q2 2026, an estimated $258K.
  • Zymeworks made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #2109 holding.
  • Vanguard Portfolio Management first reported a position in Zymeworks in Q1 2026 and has held it in 2 quarters since.
  • 201 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.